Clinical Trials Browser

Recurrence × Denosumab × Plasma cell × Clear all

NCT00259740 2017-03-15

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

Phase 2 Completed

96 enrolled 7 charts

Multiple Myeloma, Recurrence